CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day ...
CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the journal Pain Medicine, “Comparison of Percutaneous 60-Day Peripheral Nerve Stimulation of the Lumbar Medial Branches to Usual Care with ...
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter study that demonstrated significant and sustained pain ...
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- ...
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR ® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results